Withdrawal of Registration Statement (ammendment) (aw)
05 April 2023 - 6:55PM
Edgar (US Regulatory)
![](https://content.edgar-online.com/edgar_conv_img/2023/04/05/0001213900-23-027434_image_001.jpg)
Jasminder Brar |
Vice President, Legal & IP, & General Counsel |
Titan Medical Inc. |
April 4, 2023 |
416.628.6875 Direct |
Jasminder.brar@titanmedicalinc.com |
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
USA
|
|
Re: |
Titan Medical Inc. |
|
Request to Withdraw Post-Effective Amendment to Form S-8 |
|
(File No. 333-229612) |
Ladies and Gentlemen:
Pursuant to Rule 477 of the Securities Act of 1933, as amended (the
“Securities Act”), Titan Medical Inc. (the “Company”) hereby requests withdrawal of its Post-Effective Amendment
No. 1 to Registration Statement on Form S-8 (File No. 333-229612), together with all exhibits and amendments thereto (the “Registration
Statement”), as the Registration Statement was filed with the Securities and Exchange Commission (the “Commission”)
in an incorrect manner. The Registration Statement was originally filed with the Commission on February 12, 2019 and was filed on a post-effective
basis on April 4, 2023.
If you have any questions with respect to this request, please contact
James Guttman, our outside counsel at Dorsey & Whitney LLP at (416) 367-7376 or the undersigned at (416) 628-6875.
Sincerely,
|
|
TITAN MEDICAL INC. |
| |
|
|
By |
/s/ Jasminder Brar |
|
|
Name: |
Jasminder Brar |
|
|
Title: |
Vice President, Legal & IP, & General Counsel |
Titan Medical (PK) (USOTC:TMDIF)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Titan Medical (PK) (USOTC:TMDIF)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über Titan Medical Inc (PK) (OTCMarkets): 0 Nachrichtenartikel
Weitere Titan Medical Inc News-Artikel